KR840007562A - 치환된 카복실산의 수지산 염의 제조방법 - Google Patents

치환된 카복실산의 수지산 염의 제조방법 Download PDF

Info

Publication number
KR840007562A
KR840007562A KR1019840000085A KR840000085A KR840007562A KR 840007562 A KR840007562 A KR 840007562A KR 1019840000085 A KR1019840000085 A KR 1019840000085A KR 840000085 A KR840000085 A KR 840000085A KR 840007562 A KR840007562 A KR 840007562A
Authority
KR
South Korea
Prior art keywords
acid
copolymer
salt
substituted carboxylic
carboxylic acid
Prior art date
Application number
KR1019840000085A
Other languages
English (en)
Other versions
KR900006747B1 (ko
Inventor
칸드라 카나 사티쉬
Original Assignee
아르놀트 자일러, 에른스트 알테르
시바-가이기 아크티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아르놀트 자일러, 에른스트 알테르, 시바-가이기 아크티엔게젤샤프트 filed Critical 아르놀트 자일러, 에른스트 알테르
Publication of KR840007562A publication Critical patent/KR840007562A/ko
Application granted granted Critical
Publication of KR900006747B1 publication Critical patent/KR900006747B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/44—Preparation of metal salts or ammonium salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

내용 없음.

Description

치환된 카복실산의 수지산 염의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
본 발명 화합물과 볼타렌(voltoren)정제 및 서방출 정제의 생물학적 이용률을 비교한 것이다.

Claims (2)

  1. 다음 구조식(II)의 0-(2,6-디클로로 아닐리노)페닐아세트산 또는 이의 염을 다음 일반식(Ia)의 수지 또는 이의 산과이 염과 반응시킴을 특징으로 하여 다음 일반식(I)의 수지산 염을 제조하는 방법.
    상기식에서, Am은 양이온 형태인, 스티렌 및 디비닐벤젠의 강염기성 공중합체이고[여기에서, 공중합체는 m+n개의 4급 암모늄 그룹 및 주요 구조 단위로서, 다음 구조식의 그룹을 갖는다.]
    X는 다음 구조식의 음이온과 다른 산의 음이온이고
    m 및 n은 분자량이 약 107내지 109인 공중합체의 전체 이온 용량을 나타낸다.
  2. 제1항에 있어서, 이온교환 수지에 대한 활성 성분의 화학양론비가 1 : 1 내지 1 : 2인 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019840000085A 1983-01-12 1984-01-11 치환된 카복실산의 수지산염의 제조방법 KR900006747B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH147/83-1 1983-01-12
CH14783A CH655507B (ko) 1983-01-12 1983-01-12

Publications (2)

Publication Number Publication Date
KR840007562A true KR840007562A (ko) 1984-12-08
KR900006747B1 KR900006747B1 (ko) 1990-09-20

Family

ID=4180317

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840000085A KR900006747B1 (ko) 1983-01-12 1984-01-11 치환된 카복실산의 수지산염의 제조방법

Country Status (41)

Country Link
US (1) US4510128A (ko)
EP (1) EP0122219B1 (ko)
JP (1) JPS59134759A (ko)
KR (1) KR900006747B1 (ko)
AR (1) AR240310A1 (ko)
AT (2) AT391467B (ko)
AU (1) AU570230B2 (ko)
BE (1) BE898649A (ko)
CA (1) CA1218077A (ko)
CH (1) CH655507B (ko)
CS (1) CS269954B2 (ko)
DD (1) DD218373A5 (ko)
DE (2) DE3474152D1 (ko)
DK (1) DK166683B1 (ko)
DZ (1) DZ593A1 (ko)
EG (1) EG16562A (ko)
ES (1) ES528770A0 (ko)
FI (1) FI82682C (ko)
FR (1) FR2542735B1 (ko)
GB (1) GB2134529B (ko)
GR (1) GR79793B (ko)
HK (1) HK90390A (ko)
HU (1) HU190750B (ko)
IE (1) IE56545B1 (ko)
IL (1) IL70660A (ko)
IT (1) IT1177501B (ko)
LU (1) LU85171A1 (ko)
MA (1) MA20000A1 (ko)
MC (1) MC1564A1 (ko)
MT (1) MTP943B (ko)
NL (1) NL8400098A (ko)
NO (1) NO162862C (ko)
NZ (1) NZ206815A (ko)
OA (1) OA07628A (ko)
PH (1) PH21795A (ko)
PL (1) PL142737B1 (ko)
PT (1) PT77932B (ko)
RO (1) RO88481A (ko)
SE (1) SE457959B (ko)
ZA (1) ZA84212B (ko)
ZW (1) ZW484A1 (ko)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH664085A5 (de) * 1985-02-08 1988-02-15 Ciba Geigy Ag Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung.
ES8604955A1 (es) * 1985-11-08 1986-03-16 Covex Sa Procedimiento para la preparacion de resinatos de la (-) eburnamenina-14-(15h)-ona
GB8730010D0 (en) * 1987-12-23 1988-02-03 Smith Kline French Lab Compounds
AU608114B2 (en) * 1987-12-23 1991-03-21 Smith Kline & French Laboratories Limited Compounds
US5230885A (en) * 1987-12-23 1993-07-27 Smith Kline & French Laboratories Limited Polystyrene anion exchange polymer pharmaceutical composition
CH675537A5 (ko) * 1988-03-25 1990-10-15 Ciba Geigy Ag
SE509029C2 (sv) * 1988-08-16 1998-11-30 Ss Pharmaceutical Co Långtidsverkande diklofenak-natriumpreparat
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
EP0373103B1 (de) * 1988-11-10 1993-03-31 Ciba-Geigy Ag Flüssige orale Formulierung
CA2002492A1 (en) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition
GB8911719D0 (en) * 1989-05-22 1989-07-05 Smith Kline French Lab Compounds
GB8913700D0 (en) * 1989-06-14 1989-08-02 Smith Kline French Lab Compounds
GB8913699D0 (en) * 1989-06-14 1989-08-02 Smith Kline French Lab Compounds
US5079001A (en) * 1989-11-03 1992-01-07 Ciba-Geigy Corporation Liquid oral formulation of diclofenac
GB8928278D0 (en) * 1989-12-14 1990-02-21 Smith Kline French Lab Compounds
SE9004129D0 (sv) * 1990-12-21 1990-12-21 Pharmacia Lkb Biotech Anion exchanger
CA2112751A1 (en) * 1991-07-03 1993-01-21 Charles J. Ii Betlach Composition and method for transdermal delivery of diclofenac
EP1250937B1 (en) * 2001-04-09 2009-05-13 Rohm And Haas Company Controlled dissolution of active ingredients
US20020176842A1 (en) * 2001-04-09 2002-11-28 Lyn Hughes Extended release of active ingredients
US20030180249A1 (en) * 2002-03-18 2003-09-25 Khanna Satish Chandra Dosage forms for hygroscopic active ingredients
US20050036977A1 (en) * 2003-08-11 2005-02-17 Dilip Gole Taste-masked resinate and preparation thereof
EP1830851A2 (en) * 2004-12-06 2007-09-12 Themis Laboratories Private Limited Rapid disintegrating taste masked compositions and a process for its preparations
RU2435569C2 (ru) 2006-03-16 2011-12-10 Трис Фарма, Инк. Композиции с модифицированным высвобождением, содержащие комплексы лекарственное вещество - ионообменная смола
US7799347B2 (en) * 2006-09-07 2010-09-21 Chondrex Inc. Endotoxin-adsorbent for the prevention and treatment of autoimmune diseases
JP5670336B2 (ja) * 2008-10-02 2015-02-18 ユニヴァーシティ オヴ ピッツバーグ オヴ ザ コモンウェルス システム オヴ ハイアー エデュケーション 全身性炎症の治療のためのポリマー吸着剤の投与
CA2794171C (en) 2010-03-24 2018-07-03 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
DK2884961T3 (en) 2012-08-15 2019-04-23 Tris Pharma Inc METHYLPHENIDATE TABLE WITH EXTENDED RELEASE
US10398662B1 (en) 2015-02-18 2019-09-03 Jazz Pharma Ireland Limited GHB formulation and method for its manufacture
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
UY37341A (es) 2016-07-22 2017-11-30 Flamel Ireland Ltd Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US20180263936A1 (en) 2017-03-17 2018-09-20 Jazz Pharmaceuticals Ireland Limited Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
CN113395960A (zh) 2018-11-19 2021-09-14 爵士制药爱尔兰有限公司 抗酒精药物制剂
US11400065B2 (en) 2019-03-01 2022-08-02 Flamel Ireland Limited Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB857193A (en) * 1957-03-14 1960-12-29 Clinical Products Ltd Resin-drug compounds
GB823000A (en) * 1957-10-03 1959-11-04 Clinical Products Ltd Resin-drug compounds
GB869149A (en) * 1958-09-16 1961-05-31 Clinical Products Ltd Liquid pharmaceutical compositions comprising compounds of ion exchange resins and therapeutic substances
US3316282A (en) * 1965-02-08 1967-04-25 Squibb & Sons Inc Anion exchange resin complex of a cycloborate ester of a steroid
NO125724B (ko) * 1967-12-20 1972-10-23 Ciba Geigy Ag
CH519476A (de) * 1968-03-30 1972-02-29 Hoechst Ag Verfahren zur Herstellung von Salzen von Acylamino-alkylbenzolsulfonyl-harnstoffen mit Anionenaustauschern
US3926864A (en) * 1971-06-21 1975-12-16 Ionics Ion exchange membranes having a macroporous surface area
GB1423694A (en) * 1973-07-10 1976-02-04 Beecham Group Ltd Pharmaceutical compositions
US4058491A (en) * 1975-02-11 1977-11-15 Plastomedical Sciences, Inc. Cationic hydrogels based on heterocyclic N-vinyl monomers
FR2352547A1 (fr) * 1976-05-25 1977-12-23 Viridis Ets Nouvelle resine anionique a action hypocholesterolemiante, son procede de preparation et compositions therapeutiques la contenant
US4217421A (en) * 1977-06-27 1980-08-12 Rohm And Haas Company Anion exchange resins prepared from crosslinked polystyrenesulfonylchloride
US4380590A (en) * 1978-09-19 1983-04-19 Rohm And Haas Company Emulsion copolymer cation exchange resins
IT1106718B (it) * 1978-12-21 1985-11-18 Alfa Farmaceutici Spa Composizioni a base di resine anioniche salificate farmacologicamente attive
US4207399A (en) * 1979-03-14 1980-06-10 Rohm And Haas Company Methylquinoline high polymer based on quaternary ammonium polymers
US4302548A (en) * 1980-05-22 1981-11-24 Rohm And Haas Company Production of ion exchange resins, the resins so produced and ion exchange processes using them

Also Published As

Publication number Publication date
NL8400098A (nl) 1984-08-01
DZ593A1 (fr) 2004-09-13
ZW484A1 (en) 1984-08-08
MTP943B (en) 1984-06-05
AT391467B (de) 1990-10-10
PL245656A1 (en) 1985-01-02
KR900006747B1 (ko) 1990-09-20
DD218373A5 (de) 1985-02-06
SE8400098D0 (sv) 1984-01-10
HUT34151A (en) 1985-02-28
MC1564A1 (fr) 1984-11-12
JPH0257058B2 (ko) 1990-12-03
FI82682B (fi) 1990-12-31
JPS59134759A (ja) 1984-08-02
AR240310A1 (es) 1990-03-30
NO162862B (no) 1989-11-20
IE56545B1 (en) 1991-08-28
AU570230B2 (en) 1988-03-10
SE8400098L (sv) 1984-07-13
MA20000A1 (fr) 1984-10-01
PH21795A (en) 1988-02-29
RO88481A (ro) 1986-01-30
DE3474152D1 (en) 1988-10-27
CS269954B2 (en) 1990-05-14
NO162862C (no) 1990-02-28
GB8400251D0 (en) 1984-02-08
OA07628A (fr) 1985-05-23
GB2134529B (en) 1986-09-24
CS17884A2 (en) 1989-10-13
PT77932A (en) 1984-02-01
EP0122219B1 (de) 1988-09-21
ATE37378T1 (de) 1988-10-15
DE3400491C2 (ko) 1988-11-10
IL70660A (en) 1987-08-31
IT1177501B (it) 1987-08-26
BE898649A (fr) 1984-07-11
LU85171A1 (de) 1984-10-24
PT77932B (en) 1986-07-22
US4510128A (en) 1985-04-09
HK90390A (en) 1990-11-09
CH655507B (ko) 1986-04-30
PL142737B1 (en) 1987-11-30
ATA784A (de) 1990-04-15
ZA84212B (en) 1984-08-29
GB2134529A (en) 1984-08-15
SE457959B (sv) 1989-02-13
GR79793B (ko) 1984-10-31
IL70660A0 (en) 1984-04-30
CA1218077A (en) 1987-02-17
DK11884A (da) 1984-07-13
IE840049L (en) 1984-07-12
IT8447527A0 (it) 1984-01-10
NO840090L (no) 1984-07-13
DK166683B1 (da) 1993-06-28
FI82682C (fi) 1991-04-10
DK11884D0 (da) 1984-01-11
HU190750B (en) 1986-10-28
EP0122219A3 (en) 1985-05-08
EP0122219A2 (de) 1984-10-17
EG16562A (en) 1991-12-30
FR2542735A1 (fr) 1984-09-21
FR2542735B1 (fr) 1986-04-18
ES8504849A1 (es) 1985-05-01
ES528770A0 (es) 1985-05-01
FI840069A (fi) 1984-07-13
DE3400491A1 (de) 1984-07-12
FI840069A0 (fi) 1984-01-09
AU2323084A (en) 1984-07-19
NZ206815A (en) 1986-08-08

Similar Documents

Publication Publication Date Title
KR840007562A (ko) 치환된 카복실산의 수지산 염의 제조방법
BE851708A (fr) Procede de preparation d'acide terephtalique
FR2341552A1 (fr) Procede de preparation d'acide methacrylique
FR2313069A1 (fr) Composes d'acide 3-substitue-7-alcanamido substitue-3-cephem-4-carboxylique, leurs procedes de preparation et leur utilisation comme agents a activite antimicrobienne
BE847153A (fr) Procede de preparation d'acide formique pur,
ZA796154B (en) Tablets
FR2338922A1 (fr) Procede de preparation de sels d'acide 3,3-dimethyl-2-oxobutyrique
BE834080A (fr) Procede de preparation d'acide 5-fluoro-2-methyl-1-(p-methyls ulfinylbenzylidene)-indenyl-3-acetique
BE848143A (fr) Procede de preparation de l'acide cis-2-hydroxy-2-phenyl-r-1-cyclohexanecarboxylique,
PT67185B (fr) Procede de preparation d'acide terephtalique
BE841209A (fr) Procede de preparation de solutions d'acide perpropionique
FR2295952A1 (fr) Procede de preparation d'acide 3,6-dichloropicolinique
BE847024A (fr) Ester o,o-diethyle et 0-(n-methoxy-2-nitrobenzimidoyle) d'acide thionophorique, son procede de preparation et son application comme insecticides et acaricide
BE841210A (fr) Procede de preparation de solutions d'acide perpropionique
KR840001178A (ko) N-메틸-d-글루카민염의 제조
FR2316232A1 (fr) Procede de preparation d'acide 5-alcoyl-picolique
BE769805A (fr) Nouveaux esteramides d'acide thionothiolphosphorique, leur procede de preparation et leur utilisation comme nematocides, insecticides et acaricides
BE875728R (fr) Procede de preparation d'acide terephtalique
LU81501A1 (fr) Compositions pharmaceutiques comprenant de la trimethoprime,ainsi que des derives d'acides n-ethyl-gamma-pyridone-3-carboxyliques
JPS5393180A (en) Diffusing and dialyzing for solution containing base
BE856559A (fr) Procede de preparation d'acide isobutyrique
BE846827A (fr) Procede de preparation d'acide fluorhydrique de grande purete,
FR2340952A1 (fr) Procede de preparation d'un alcaloide de type di-indol ou ses sels d'additions avec un acide, pharmaceutiquement actifs, ainsi que des compositions pharmaceutiques le contenant
BE866223A (fr) Procede de preparation d'acide naphtalene-1, 3, 6-trisulfonique
AT216137B (de) Verfahren zur Herstellung eines therapeutischen Präparates

Legal Events

Date Code Title Description
N231 Notification of change of applicant
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20020816

Year of fee payment: 13

LAPS Lapse due to unpaid annual fee